Citations (80)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Paul Munson. (2022) Progress Towards a Therapeutic HIV DNA Vaccine. Expert Review of Vaccines 21:6, pages 783-798.
Read now
Read now
Xiaoling Xu, Zichao Zhou, Hui Li & Yun Fan. (2021) Towards customized cancer vaccines: a promising filed in personalized cancer medicine. Expert Review of Vaccines 20:5, pages 545-557.
Read now
Read now
Fang Huang, Jinjin Zhao, Yiting Wei, Zhifa Wen, Yue Zhang, Xuru Wang, Yanfei Shen, Li-xin Wang & Ning Pan. (2020) Anti-Tumor Efficacy of an Adjuvant Built-In Nanovaccine Based on Ubiquitinated Proteins from Tumor Cells. International Journal of Nanomedicine 15, pages 1021-1035.
Read now
Read now
Bernardo Pereira Cabral, Maria da Graça Derengowski Fonseca & Fabio Batista Mota. (2019) What is the future of cancer care? A technology foresight assessment of experts’ expectations. Economics of Innovation and New Technology 28:6, pages 635-652.
Read now
Read now
Articles from other publishers (76)
Nian Liu, Xiangyu Xiao, Ziqiang Zhang, Chun Mao, Mimi Wan & Jian Shen. (2023) Advances in Cancer Vaccine Research. ACS Biomaterials Science & Engineering 9:11, pages 5999-6023.
Crossref
Crossref
Wenqi Sun, Panpan Ji, Tian Zhou, Zhelong Li, Changyang Xing, Liang Zhang, Mengying Wei, Guodong Yang & Lijun Yuan. (2023) Ultrasound Responsive Nanovaccine Armed with Engineered Cancer Cell Membrane and RNA to Prevent Foreseeable Metastasis. Advanced Science 10:19.
Crossref
Crossref
Samvedna Saini, Pranjal Dagar, Sakshi Gupta & Yatender Kumar. (2023) A nanotherapeutic approach for fighting the odds against the malignant disorders. Journal of Nanoparticle Research 25:6.
Crossref
Crossref
Kiarash Saleki & Nima Rezaei. 2022. Handbook of Cancer and Immunology. Handbook of Cancer and Immunology
1
25
.
Morgan Marriott, Brittany Post & Lipika Chablani. (2022) A Comparison of Cancer Vaccine Adjuvants in Clinical Trials. Cancer Treatment and Research Communications, pages 100667.
Crossref
Crossref
Madhu Gupta, Abhishek Wahi, Priyanka Sharma, Riya Nagpal, Neha Raina, Monika Kaurav, Jaydeep Bhattacharya, Sonia M. Rodrigues Oliveira, Karma G. Dolma, Alok K. Paul, Maria de Lourdes Pereira, Polrat Wilairatana, Mohammed Rahmatullah & Veeranoot Nissapatorn. (2022) Recent Advances in Cancer Vaccines: Challenges, Achievements, and Futuristic Prospects. Vaccines 10:12, pages 2011.
Crossref
Crossref
Hyunjung Kim, Di Bai, Sadashib Ghosh, Michael L. Franks, Xifeng Wang, Cheng Yan, Zheng Liu, Ping Zhang, Suzanne M. Michalek, Jianmei W. Leavenworth & Pengfei Wang. (2022)
Structure–Activity Relationship Study of
Momordica
Saponin II Derivatives as Vaccine Adjuvants
. Journal of Medicinal Chemistry 65:21, pages 14589-14598.
Crossref
Crossref
Brett H. Pogostin, Marina H. Yu, Alon R. Azares, Erin M. Euliano, Cheuk Sun Edwin Lai, Gabriel Saenz, Samuel X. Wu, Adam C. Farsheed, Sarah M. Melhorn, Tyler P. Graf, Darren G. Woodside, Jeffrey D. Hartgerink & Kevin J. McHugh. (2022) Multidomain peptide hydrogel adjuvants elicit strong bias towards humoral immunity. Biomaterials Science 10:21, pages 6217-6229.
Crossref
Crossref
Noopur Bhatnagar, Ki-Hye Kim, Jeeva Subbiah, Bo Ryoung Park, Pengfei Wang, Harvinder Singh Gill, Bao-Zhong Wang & Sang-Moo Kang. (2022) Adjuvant Effects of a New Saponin Analog VSA-1 on Enhancing Homologous and Heterosubtypic Protection by Influenza Virus Vaccination. Vaccines 10:9, pages 1383.
Crossref
Crossref
Liuyang He, Yu Bai, Lei Xia, Jie Pan, Xiao Sun, Zhichao Zhu, Jun Ding, Chunjian Qi & Cui Tang. (2022) Oral administration of a whole glucan particle (WGP)-based therapeutic cancer vaccine targeting macrophages inhibits tumor growth. Cancer Immunology, Immunotherapy 71:8, pages 2007-2028.
Crossref
Crossref
Mahnaz Rezaei, Natalia D. Danilova, Mojdeh Soltani, Lyudmila V. Savvateeva, Vadim V. Tarasov, Mazdak Ganjalikhani-Hakemi, Alexandr V. Bazhin & Andrey A. Zamyatnin. (2022) Cancer Vaccine in Cold Tumors: Clinical Landscape, Challenges, and
Opportunities. Current Cancer Drug Targets 22:6, pages 437-453.
Crossref
Crossref
Xiaoyi Hu, Weilin Zhou, Ruyu Pi, Xia Zhao & Wei Wang. (2022) Genetically modified cancer vaccines: Current status and future prospects. Medicinal Research Reviews 42:4, pages 1492-1517.
Crossref
Crossref
Anna Bogdanova, Charles Andrawos & Constantina Constantinou. (2022) Cervical cancer, geographical inequalities, prevention and barriers in resource depleted countries (Review). Oncology Letters 23:4.
Crossref
Crossref
Xin Li, Chao Pan, Peng Sun, Zhehui Peng, Erling Feng, Jun Wu, Hengliang Wang & Li Zhu. (2021) Orthogonal modular biosynthesis of nanoscale conjugate vaccines for vaccination against infection. Nano Research 15:2, pages 1645-1653.
Crossref
Crossref
Roberto Raúl Servin-Garrido, Damaris Ilhuicatzi-Alvarado, Ángel de Jesús Jiménez-Chávez & Leticia Moreno-Fierros. (2022) Cry1Ac Protoxin Confers Antitumor Adjuvant Effect in a Triple-Negative Breast Cancer Mouse Model by Improving Tumor Immunity. Breast Cancer: Basic and Clinical Research 16, pages 117822342110651.
Crossref
Crossref
Dharmendra Kumar Khatri, Jitender Madan, Kiran Jyoti & Shashi Bala Singh. 2022. Multifunctional Nanocarriers. Multifunctional Nanocarriers
347
377
.
Yingyue Ding & Quanyin Hu. 2022. Stimuli-Responsive Nanocarriers. Stimuli-Responsive Nanocarriers
171
195
.
Md Akbar, Hasan Ali, Deepak Bedanand Jha, Sarwar Beg, Kainat Alam & Mahfoozur Rahman. 2022. Nanotherapeutics in Cancer Vaccination and Challenges. Nanotherapeutics in Cancer Vaccination and Challenges
217
240
.
Jose de Brito Vieira Neto, Maria Francilene Souza Silva, Lana Grasiela Alves Marques, Carlos Roberto Koscky Paier, Paulo Michel Pinheiro Ferreira & Claudia Pessoa. 2022. Plants and Phytomolecules for Immunomodulation. Plants and Phytomolecules for Immunomodulation
519
541
.
Zhongkun Zhang, Jimmy Chun-Tien Kuo, Siyu Yao, Chi Zhang, Hira Khan & Robert J. Lee. (2021) CpG Oligodeoxynucleotides for Anticancer Monotherapy from Preclinical Stages to Clinical Trials. Pharmaceutics 14:1, pages 73.
Crossref
Crossref
Zhongkun Zhang, Jimmy Chun-Tien Kuo, Chi Zhang, Yirui Huang, Zerui Zhou & Robert J. Lee. (2021) A Squalene-Based Nanoemulsion for Therapeutic Delivery of Resiquimod. Pharmaceutics 13:12, pages 2060.
Crossref
Crossref
Tingting Wang, Zhihao Wang, Jielan Mi, Wenqian Wang, Kai Li, Xiaole Qi, Yulong Gao, Li Gao, Changjun Liu, Yanping Zhang, Qing Pan, Xiaomei Wang & Hongyu Cui. (2021) Recombinant Avian β-Defensin Produced by Food-Grade Lactococcus as a Novel and Potent Immunological Enhancer Adjuvant for Avian Vaccine. Probiotics and Antimicrobial Proteins 13:6, pages 1833-1846.
Crossref
Crossref
Zhenchuan Wu & Keqin Liu. (2021) Overview of vaccine adjuvants. Medicine in Drug Discovery 11, pages 100103.
Crossref
Crossref
Jasmine Kaur, Jackson Elms, Alan L. Munn, David Good & Ming Q. Wei. (2021) Immunotherapy for non-small cell lung cancer (NSCLC), as a stand-alone and in combination therapy. Critical Reviews in Oncology/Hematology 164, pages 103417.
Crossref
Crossref
Kyong‐Su Park, Kristina Svennerholm, Rossella Crescitelli, Cecilia Lässer, Inta Gribonika & Jan Lötvall. (2021) Synthetic bacterial vesicles combined with tumour extracellular vesicles as cancer immunotherapy. Journal of Extracellular Vesicles 10:9.
Crossref
Crossref
Pengfei Wang. (2021) Natural and Synthetic Saponins as Vaccine Adjuvants. Vaccines 9:3, pages 222.
Crossref
Crossref
Stefania Cuzzubbo, Sara Mangsbo, Divya Nagarajan, Kinana Habra, Alan Graham Pockley & Stephanie E. B. McArdle. (2021) Cancer Vaccines: Adjuvant Potency, Importance of Age, Lifestyle, and Treatments. Frontiers in Immunology 11.
Crossref
Crossref
Serge Moffett, Tze Chieh Shiao, Leila Mousavifar, Serge Mignani & René Roy. (2020) Aberrant glycosylation patterns on cancer cells: Therapeutic opportunities for glycodendrimers/metallodendrimers oncology. WIREs Nanomedicine and Nanobiotechnology 13:1.
Crossref
Crossref
Đani Škalamera, Hyunjung Kim, Ping Zhang, Suzanne M. Michalek & Pengfei Wang. (2020) Impact of C28 Oligosaccharide on Adjuvant Activity of QS-7 Analogues. The Journal of Organic Chemistry 85:24, pages 15837-15848.
Crossref
Crossref
Virgil Schijns, Alberto Fernández‐Tejada, Žarko Barjaktarović, Ilias Bouzalas, Jens Brimnes, Sergey Chernysh, Sveinbjorn Gizurarson, Ihsan Gursel, Žiga Jakopin, Maria Lawrenz, Cristina Nativi, Stephane Paul, Gabriel Kristian Pedersen, Camillo Rosano, Ane Ruiz‐de‐Angulo, Bram Slütter, Aneesh Thakur, Dennis Christensen & Ed C. Lavelle. (2020) Modulation of immune responses using adjuvants to facilitate therapeutic vaccination. Immunological Reviews 296:1, pages 169-190.
Crossref
Crossref
Xue Li, Xiaoyao Cai, Zhanzhan Zhang, Yuxun Ding, Rujiang Ma, Fan Huang, Yang Liu, Jianfeng Liu & Linqi Shi. (2020) Mimetic Heat Shock Protein Mediated Immune Process to Enhance Cancer Immunotherapy. Nano Letters 20:6, pages 4454-4463.
Crossref
Crossref
Pengfei Wang, Xiong Ding, Hyunjung Kim, Suzanne M. Michalek & Ping Zhang. (2020) Structural Effect on Adjuvanticity of Saponins. Journal of Medicinal Chemistry 63:6, pages 3290-3297.
Crossref
Crossref
Cinzia Solinas, Marco Aiello, Edoardo Migliori, Karen Willard-Gallo & Leisha A. Emens. (2020) Breast cancer vaccines: Heeding the lessons of the past to guide a path forward. Cancer Treatment Reviews 84, pages 101947.
Crossref
Crossref
Neha Parayath, Smrithi Padmakumar, Shantikumar V. Nair, Deepthy Menon & Mansoor M. Amiji. (2019) Strategies for Targeting Cancer Immunotherapy Through Modulation of the Tumor Microenvironment. Regenerative Engineering and Translational Medicine 6:1, pages 29-49.
Crossref
Crossref
Michael J. Topper, Michelle Vaz, Kristen A. Marrone, Julie R. Brahmer & Stephen B. Baylin. (2019) The emerging role of epigenetic therapeutics in immuno-oncology. Nature Reviews Clinical Oncology 17:2, pages 75-90.
Crossref
Crossref
Marina A. Dobrovolskaia. (2019) Nucleic Acid Nanoparticles at a Crossroads of Vaccines and Immunotherapies. Molecules 24:24, pages 4620.
Crossref
Crossref
Pengfei Wang, Xiong Ding, Hyunjung Kim, Đani Škalamera, Suzanne M. Michalek & Ping Zhang. (2019)
Vaccine Adjuvants Derivatized from
Momordica
Saponins I and II
. Journal of Medicinal Chemistry 62:21, pages 9976-9982.
Crossref
Crossref
Hiroto Matsui, Shoichi Hazama, Koji Tamada, Keiko Udaka, Atsushi Irie, Yasuharu Nishimura, Tomoya Miyakawa, Shun Doi, Masao Nakajima, Shinsuke Kanekiyo, Yukio Tokumitsu, Yoshitaro Shindo, Shinobu Tomochika, Shin Yoshida, Michihisa Iida, Nobuaki Suzuki, Shigeru Takeda, Shigeru Yamamoto, Shigefumi Yoshino, Tomio Ueno & Hiroaki Nagano. (2019) Identification of a Promiscuous Epitope Peptide Derived From HSP70. Journal of Immunotherapy 42:7, pages 244-250.
Crossref
Crossref
Victor G. Martinez, Danielle Park & Sophie E. Acton. (2019) Immunotherapy: breaching the barriers for cancer treatment. Philosophical Transactions of the Royal Society B: Biological Sciences 374:1779, pages 20180214.
Crossref
Crossref
Célia Jacoberger-Foissac, Hanadi Saliba, Cendrine Seguin, Anaïs Brion, Zahra Kakhi, Benoît Frisch, Sylvie Fournel & Béatrice Heurtault. (2019) Optimization of peptide-based cancer vaccine compositions, by sequential screening, using versatile liposomal platform. International Journal of Pharmaceutics 562, pages 342-350.
Crossref
Crossref
Xiaobo Wang, Shaoyi Fan, Hehai Pan, Wenli Chen & Hua Wang. (2019) Cancer immunotherapy for metastasis: past, present and future. Briefings in Functional Genomics 18:2, pages 140-146.
Crossref
Crossref
Alice Mougel, Magali Terme & Corinne Tanchot. (2019) Therapeutic Cancer Vaccine and Combinations With Antiangiogenic Therapies and Immune Checkpoint Blockade. Frontiers in Immunology 10.
Crossref
Crossref
M. A. Baryshnikova & V. S. Kosorukov. (2019) Cancer vaccine adjuvants. Russian Journal of Biotherapy 17:4, pages 36-44.
Crossref
Crossref
T. Tran, C. Blanc, C. Granier, A. Saldmann, C. Tanchot & Eric Tartour. (2018) Therapeutic cancer vaccine: building the future from lessons of the past. Seminars in Immunopathology 41:1, pages 69-85.
Crossref
Crossref
Anna-Mari Reid & Namrita Lall. 2019. Medicinal Plants. Medicinal Plants
187
213
.
Shengxian Li, Xiangru Feng, Jixue Wang, Liang He, Chunxi Wang, Jianxun Ding & Xuesi Chen. (2018) Polymer nanoparticles as adjuvants in cancer immunotherapy. Nano Research 11:11, pages 5769-5786.
Crossref
Crossref
Marc J. Braunstein, John Kucharczyk & Sylvia Adams. (2018) Targeting Toll-Like Receptors for Cancer Therapy. Targeted Oncology 13:5, pages 583-598.
Crossref
Crossref
Kun Wang, Shuman Wen, Lianghua He, Ang Li, Yan Li, Haiqing Dong, Wei Li, Tianbin Ren, Donglu Shi & Yongyong Li. (2018) “Minimalist” Nanovaccine Constituted from Near Whole Antigen for Cancer Immunotherapy. ACS Nano 12:7, pages 6398-6409.
Crossref
Crossref
David Urbanavicius, Tara Alvarez, Georgina K. Such, Angus P.R. Johnston & Justine D. Mintern. (2018) The potential of nanoparticle vaccines as a treatment for cancer. Molecular Immunology 98, pages 2-7.
Crossref
Crossref
Blake Alan Scott, Mark YarchoanElizabeth M. Jaffee. (2018) Prophylactic Vaccines for Nonviral Cancers. Annual Review of Cancer Biology 2:1, pages 195-211.
Crossref
Crossref
Wei Wang, Yanqin Li, Yawen Wang, Shuting Ren, Yiping Li & Bing Wang. (2018) Polyactin A is a novel and potent immunological adjuvant for peptide-based cancer vaccine. International Immunopharmacology 54, pages 95-102.
Crossref
Crossref
Vito Pistoia, Ignazia Prigione & Lizzia Raffaghello. 2018. Immunotherapy for Pediatric Malignancies. Immunotherapy for Pediatric Malignancies
243
257
.
J. Hammerbacher & A. Snyder. (2017) Informatics for cancer immunotherapy. Annals of Oncology 28, pages xii56-xii73.
Crossref
Crossref
Wantong Song, Sara N. Musetti & Leaf Huang. (2017) Nanomaterials for cancer immunotherapy. Biomaterials 148, pages 16-30.
Crossref
Crossref
M. Speir, A. Authier-Hall, C. R. Brooks, K. J. Farrand, B. J. Compton, R. J. Anderson, A. Heiser, T. L. Osmond, C. W. Tang, J. A. Berzofsky, M. Terabe, G. F. Painter, I. F. Hermans & R. Weinkove. (2017) Glycolipid-peptide conjugate vaccines enhance CD8+ T cell responses against human viral proteins. Scientific Reports 7:1.
Crossref
Crossref
María B. Pampena, María M. Barrio, Estefanía P. Juliá, Paula A. Blanco, Erika M. von Euw, José Mordoh & Estrella Mariel Levy. (2017) Early Events of the Reaction Elicited by CSF-470 Melanoma Vaccine Plus Adjuvants: An In Vitro Analysis of Immune Recruitment and Cytokine Release. Frontiers in Immunology 8.
Crossref
Crossref
Jason Lohmueller & Olivera J. Finn. (2017) Current modalities in cancer immunotherapy: Immunomodulatory antibodies, CARs and vaccines. Pharmacology & Therapeutics 178, pages 31-47.
Crossref
Crossref
Ruan F.V. Medrano, Aline Hunger, Samir Andrade Mendonça, José Alexandre M. Barbuto & Bryan E. Strauss. (2017) Immunomodulatory and antitumor effects of type I interferons and their application in cancer therapy. Oncotarget 8:41, pages 71249-71284.
Crossref
Crossref
Xiang Zhou & Zhengfan Jiang. (2017) STING-mediated DNA sensing in cancer immunotherapy. Science China Life Sciences 60:6, pages 563-574.
Crossref
Crossref
Jeff Kamta, Maher Chaar, Anusha Ande, Deborah A. Altomare & Sihem Ait-Oudhia. (2017) Advancing Cancer Therapy with Present and Emerging Immuno-Oncology Approaches. Frontiers in Oncology 7.
Crossref
Crossref
R. Brehler. (2017) AdjuvanzienAdjuvants. Der Hautarzt 68:4, pages 292-296.
Crossref
Crossref
Mary Speir, Ian F. Hermans & Robert Weinkove. (2016) Engaging Natural Killer T Cells as ‘Universal Helpers’ for Vaccination. Drugs 77:1, pages 1-15.
Crossref
Crossref
Ji-Kun Li, Jesse J. Balic, Liang Yu & Brendan Jenkins. 2017. Regulation of Inflammatory Signaling in Health and Disease. Regulation of Inflammatory Signaling in Health and Disease
195
212
.
Tabasum Mughal. (2016) Adjuvants in Allergy: Elevating Efficacy. EMJ Allergy & Immunology, pages 32-36.
Crossref
Crossref
Tom Y.-H. Wu. (2016) Strategies for designing synthetic immune agonists. Immunology 148:4, pages 315-325.
Crossref
Crossref
Burcu Temizoz, Etsushi Kuroda & Ken J. Ishii. (2016) Vaccine adjuvants as potential cancer immunotherapeutics. International Immunology 28:7, pages 329-338.
Crossref
Crossref
Xiupeng Wang, Xia Li, Atsuo Ito, Kazuko Yoshiyuki, Yu Sogo, Yohei Watanabe, Atsushi Yamazaki, Tadao Ohno & Noriko M. Tsuji. (2016) Hollow Structure Improved Anti-Cancer Immunity of Mesoporous Silica Nanospheres In Vivo. Small 12:26, pages 3510-3515.
Crossref
Crossref
Yosuke Kano, Takahiro Iguchi, Hiroto Matsui, Keishi Adachi, Yukimi Sakoda, Tomoya Miyakawa, Shun Doi, Shoichi Hazama, Hiroaki Nagano, Yoshiya Ueyama & Koji Tamada. (2016)
Combined adjuvants of poly(I:C) plus
LAG
‐3‐Ig improve antitumor effects of tumor‐specific T cells, preventing their exhaustion
. Cancer Science 107:4, pages 398-406.
Crossref
Crossref
Olivera J Finn & Pamela L Beatty. (2016) Cancer immunoprevention. Current Opinion in Immunology 39, pages 52-58.
Crossref
Crossref
Lan Wang, Jueheng Wu, Jie Yuan, Xun Zhu, Hongmei Wu & Mengfeng Li. (2016) Midline2 is overexpressed and a prognostic indicator in human breast cancer and promotes breast cancer cell proliferation in vitro and in vivo. Frontiers of Medicine 10:1, pages 41-51.
Crossref
Crossref
Tammy Oth, Joris Vanderlocht, Catharina H. M. J. Van Elssen, Gerard M. J. Bos & Wilfred T. V. Germeraad. (2016) Pathogen-Associated Molecular Patterns Induced Crosstalk between Dendritic Cells, T Helper Cells, and Natural Killer Helper Cells Can Improve Dendritic Cell Vaccination. Mediators of Inflammation 2016, pages 1-12.
Crossref
Crossref
Zhenlong Ye, Zhong Li, Huajun Jin & Qijun Qian. 2016. Progress in Cancer Immunotherapy. Progress in Cancer Immunotherapy
139
167
.
Ping Zhou, Qilin Zhang, Yao Zhao, Hongying Sha, Xiaoyun Cao & Yongfei Wang. (2015) IL-17 promoted the inhibition of medulloblastoma in mice by splenocyte injection. European Journal of Medical Research 20:1.
Crossref
Crossref
Hua Yue & Guanghui Ma. (2015) Polymeric micro/nanoparticles: Particle design and potential vaccine delivery applications. Vaccine 33:44, pages 5927-5936.
Crossref
Crossref
A. Galliher-Beckley, L.K. Pappan, Rachel Madera, Y. Burakova, A. Waters, M. Nickles, X. Li, J. Nietfeld, J.R. Schlup, Q. Zhong, S. McVey, S.S. Dritz & J. Shi. (2015) Characterization of a novel oil-in-water emulsion adjuvant for swine influenza virus and Mycoplasma hyopneumoniae vaccines. Vaccine 33:25, pages 2903-2908.
Crossref
Crossref
Mladen Korbelik, Judit Banath, Evaldas Čiplys, Zdzislaw Szulc, Alicja Bielawska & Wei R. Chen. Activity of glycated chitosan and other adjuvants to PDT vaccines. Activity of glycated chitosan and other adjuvants to PDT vaccines.